Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
Alyssa Tapley, 16, became the first patient with an aggressive form of leukaemia to have the experimental treatment in 2022.
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
1h
CDT1 overexpression suppresses DNA replication and triggers DNA damage linked to cancer, finds study
A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA ...
Detectives often find important clues by digging through rubbish. That approach paid off tremendously for systems biologist ...
A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...
High-resolution imaging has revealed the internal layout of chromatin condensates, showing how DNA fibers fold and interact ...
Interdisciplinary scientist brings expertise in molecular biology and bioinformatics to study HIV reservoir, where dormant ...
A jury convicted a Merrillville man Friday in his estranged girlfriend’s death. Dennis Jelks, 60, was found guilty of murder and a gun enhancement in the January 2021 death of Angela Carrier, 37, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback